Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Edwards

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
BMC Cancer|October 9, 2008
High-resolution array CGH clarifies events occurring on 8p in carcinogenesisSusanna L Cooke, Jessica C M Pole, Suet-Feung Chin, et al.
American Journal of Medical Genetics. Part A|February 28, 2008
Molecular cytogenetic characterization of a unique and complex de novo 8p rearrangementSusanna L Cooke, Jill K Northup, Neena L Champaige, et al.
Genome Research|January 22, 2011
Large duplications at reciprocal translocation breakpoints that might be the counterpart of large deletions and could arise from stalled replication bubblesKaren D Howarth, Jessica C M Pole, Juliet C Beavis, et al.
Cellular and Molecular Life Sciences : CMLS|September 28, 2019
Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylationBethany Mason, Susanne Flach, Felipe R Teixeira, et al.
F1000Research|September 6, 2016
Whole-genome sequencing of nine esophageal adenocarcinoma cell linesGianmarco Contino, Matthew D Eldridge, Maria Secrier, et al.
International Journal of Cancer|November 11, 2006
Genomic analysis of the 8p11-12 amplicon in familial breast cancerLorenzo Melchor, Maria J Garcia, Emiliano Honrado, et al.
Science Signaling|June 17, 2011
A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. CookAnnette S Little, Kathryn Balmanno, Matthew J Sale, et al.
Science Signaling|March 31, 2011
Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cellsAnnette S Little, Kathryn Balmanno, Matthew J Sale, et al.
Oncogene|April 26, 2006
High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocationJ C M Pole, C Courtay-Cahen, M J Garcia, et al.
Oncogene|October 6, 2009
The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor geneY L Chua, Y Ito, J C M Pole, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
BMC Cancer|October 9, 2008
High-resolution array CGH clarifies events occurring on 8p in carcinogenesisSusanna L Cooke, Jessica C M Pole, Suet-Feung Chin, et al.
American Journal of Medical Genetics. Part A|February 28, 2008
Molecular cytogenetic characterization of a unique and complex de novo 8p rearrangementSusanna L Cooke, Jill K Northup, Neena L Champaige, et al.
Genome Research|January 22, 2011
Large duplications at reciprocal translocation breakpoints that might be the counterpart of large deletions and could arise from stalled replication bubblesKaren D Howarth, Jessica C M Pole, Juliet C Beavis, et al.
Cellular and Molecular Life Sciences : CMLS|September 28, 2019
Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylationBethany Mason, Susanne Flach, Felipe R Teixeira, et al.
F1000Research|September 6, 2016
Whole-genome sequencing of nine esophageal adenocarcinoma cell linesGianmarco Contino, Matthew D Eldridge, Maria Secrier, et al.
International Journal of Cancer|November 11, 2006
Genomic analysis of the 8p11-12 amplicon in familial breast cancerLorenzo Melchor, Maria J Garcia, Emiliano Honrado, et al.
Science Signaling|June 17, 2011
A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. CookAnnette S Little, Kathryn Balmanno, Matthew J Sale, et al.
Science Signaling|March 31, 2011
Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cellsAnnette S Little, Kathryn Balmanno, Matthew J Sale, et al.
Oncogene|April 26, 2006
High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocationJ C M Pole, C Courtay-Cahen, M J Garcia, et al.
Oncogene|October 6, 2009
The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor geneY L Chua, Y Ito, J C M Pole, et al.
Pageof 8